Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-04

Clinical Trial Update: Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 results for a new formulation of chondroitin sulfate and glucosamine sulfate in knee osteoarthritis have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chondroitin sulfate and glucosamine sulfate (new formulation) (Chondroitin sulfate; Glucosamine sulfate)

Snippet

Sponsor: Tedec-Meiji Farma, S.A. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-04